CONMED Corporation
US ˙ NYSE ˙ US2074101013

Introduction

This page provides a comprehensive analysis of the known insider trading history of Dirk Kuyper. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Dirk Kuyper has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CNMD / CONMED Corporation Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Dirk Kuyper. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CNMD / CONMED Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CNMD / CONMED Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2013-08-15 CNMD Kuyper Dirk 1,000 31.6311 1,000 31.6311 31,631 271 49.6500 18,019 56.97

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CNMD / CONMED Corporation Insider Trades
Insider Sales CNMD / CONMED Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CNMD / CONMED Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2019-08-02 CNMD Kuyper Dirk 5,396 91.1000 5,396 91.1000 491,576 234 39.8100 -276,760 -56.30
2019-08-02 CNMD Kuyper Dirk 3,669 91.0400 3,669 91.0400 334,026
2019-08-02 CNMD Kuyper Dirk 2,549 91.1700 2,549 91.1700 232,392
2019-06-14 CNMD Kuyper Dirk 8,970 82.9953 8,970 82.9953 744,468
2017-06-13 CNMD Kuyper Dirk 1,000 52.2385 1,000 52.2385 52,238
2014-12-01 CNMD Kuyper Dirk 300 42.8500 300 42.8500 12,855
2014-12-01 CNMD Kuyper Dirk 500 42.8400 500 42.8400 21,420
2014-12-01 CNMD Kuyper Dirk 200 42.8644 200 42.8644 8,573

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CNMD / CONMED Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Dirk Kuyper as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Options To Purchase Common Stock
M - Exercise -2,549 0 -100.00
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Options To Purchase Common Stock
M - Exercise -3,669 0 -100.00
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Options To Purchase Common Stock
M - Exercise -5,396 0 -100.00
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Common Stock
S - Sale -2,549 5,000 -33.77 91.17 -232,392 455,850
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Common Stock
M - Exercise 2,549 7,549 50.98 69.03 175,957 521,107
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Common Stock
S - Sale -3,669 5,000 -42.32 91.04 -334,026 455,200
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Common Stock
M - Exercise 3,669 8,669 73.38 51.90 190,421 449,921
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Common Stock
S - Sale -5,396 5,000 -51.90 91.10 -491,576 455,500
2019-08-06 2019-08-02 4 CNMD CONMED CORP
Common Stock
M - Exercise 5,396 10,396 107.92 41.06 221,560 426,860
2019-08-06 2019-08-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
D - Sale to Issuer -1,407 0 -100.00
2019-08-06 2019-08-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
D - Sale to Issuer -2,165 0 -100.00
2019-06-18 2019-06-14 4 CNMD CONMED CORP
Common Stock
S - Sale -8,970 5,000 -64.21 83.00 -744,468 414,976
2019-06-04 2019-06-03 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 2,165 2,165
2019-06-04 2019-06-03 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1,407 1,407
2019-06-04 2019-05-31 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -1,629 0 -100.00
2019-06-04 2019-05-31 4 CNMD CONMED CORP
Common Stock
M - Exercise 1,629 13,970 13.20
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
M - Exercise X -1,000 0 -100.00
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
M - Exercise X -1,000 0 -100.00
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
M - Exercise X -1,000 0 -100.00
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Common Stock
S - Sale X -2,000 12,341 -13.95 83.39 -166,780 1,029,116
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Common Stock
F - Taxes -677 14,341 -4.51 82.38 -55,771 1,181,412
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Common Stock
M - Exercise X 1,000 15,018 7.13 55.70 55,700 836,503
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Common Stock
F - Taxes -482 14,018 -3.32 82.38 -39,707 1,154,803
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Common Stock
M - Exercise X 1,000 14,500 7.41 39.64 39,640 574,780
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Common Stock
F - Taxes -406 13,500 -2.92 82.38 -33,446 1,112,130
2019-04-09 2019-04-08 4 CNMD CONMED CORP
Common Stock
M - Exercise X 1,000 13,906 7.75 33.43 33,430 464,878
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 2,549 2,549
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 1,629 1,629
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -2,167 0 -100.00
2018-06-04 2018-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 2,167 12,906 20.18
2017-06-14 2017-06-13 4 CNMD CONMED CORP
Common Stock
S - Sale -1,000 10,739 -8.52 52.24 -52,238 560,989
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 3,669 3,669 51.90 190,421 190,421
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 2,167 2,167
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -2,739 0 -100.00
2017-06-02 2017-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 2,739 11,739 30.43
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 2,739 2,739
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Options To Purchase Common Stock
A - Award 5,396 5,396
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3,000 0 -100.00
2016-06-03 2016-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3,000 9,000 50.00
2015-07-02 2015-06-01 4/A CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1,000 1,000
2015-07-02 2015-06-01 4/A CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3,000 3,000
2015-06-03 2015-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3,000 0 -100.00
2015-06-03 2015-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3,000 6,000 100.00
2014-12-03 2014-12-01 4 CNMD CONMED CORP
Common Stock
S - Sale -200 3,000 -6.25 42.86 -8,573 128,593
2014-12-03 2014-12-01 4 CNMD CONMED CORP
Common Stock
S - Sale -500 3,200 -13.51 42.84 -21,420 137,088
2014-12-03 2014-12-01 4 CNMD CONMED CORP
Common Stock
S - Sale -300 3,700 -7.50 42.85 -12,855 158,545
2014-09-15 2014-09-11 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1,000 1,000
2014-09-15 2014-09-11 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3,000 3,000
2014-06-03 2014-06-01 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
M - Exercise -3,000 0 -100.00
2014-06-03 2014-06-01 4 CNMD CONMED CORP
Common Stock
M - Exercise 3,000 4,000 300.00
2013-08-15 2013-08-15 4 CNMD CONMED CORP
Common Stock
P - Purchase 1,000 1,000 31.63 31,631 31,631
2013-07-30 2013-07-26 4 CNMD CONMED CORP
Sars (Stock Appreciation Rights)
A - Award 1,000 1,000 33.43 33,430 33,430
2013-07-30 2013-07-26 4 CNMD CONMED CORP
Rsus (restricted Stock Units)
A - Award 3,000 3,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)